Abridge raises $340m Series D to scale ambient AI across US health systems
Spark Capital leads the round as the ambient documentation category consolidates around a small number of enterprise vendors.

Abridge, a prominent player in the burgeoning field of ambient artificial intelligence for healthcare, has successfully closed a Series D funding round, securing an impressive $340 million. The substantial investment was led by Spark Capital, a notable venture capital firm, and saw continued participation from existing high-profile investors including a16z Bio + Health and General Catalyst. This latest infusion of capital underscores the increasing investor confidence in AI-driven solutions for optimising clinical workflows within the healthcare sector.
The strategic deployment of these proceeds is notably geared towards enhancing enterprise deployment capacity rather than focusing on novel model development. This emphasis reflects a critical juncture in the ambient documentation category, where the primary bottleneck has shifted from core technological innovation to the practical challenges of integrating and scaling these sophisticated systems across large, complex health organisations. It suggests that the underlying AI models have matured sufficiently, and the immediate imperative is now operationalisation and widespread adoption.
Premium story
Create a free account for 3 premium articles a month
Free members read three premium pieces every month. Or go unlimited with Premium.
Create a free accountPremium
£29/month or £290/year
Unlimited premium analysis, The Analyst Note and the full archive.
Choose PremiumAlready a member? Sign in
Source: Financial Times
Related stories

Healthcare Technology
Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol market

Healthcare Technology
FDA extends Casgevy approval to children aged two and over, raising payer coverage questions

Healthcare Technology
Paige raises $75m Series C to widen digital pathology footprint in Europe